Hangzhou Mandy Biotechnology
Retatrutide
Finnrick tested 5 samples of Retatrutide (GLP-1, GIP, and GCGR agonist) from Hangzhou Mandy Biotechnology between 17 Nov 2025 and 15 Jan 2026. Test scores average over 6, no score below 5, and at least 2 tests warrant a tentative Finnrick Rating of B (Good).
Finnrick Rating™
Tentative Rating
Hangzhou Mandy Biotechnology
Retatrutide
Tested 5 Samples
Last test 15 Jan 2026
Take Action
Researcher
Request Full Data Access to the Finnrick database of peptide tests.
Free peptide testing
Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.
Other Retatrutide tests from top-rated vendors:
All Retatrutide tests from Hangzhou Mandy Biotechnology
Samples are tested in commercial labs
Tests Count
5
Scores
AVGMINMAX
Last
15 Jan 2026
First
17 Nov 2025
| Quantity | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Certificate | Test Score | Label | Tested | Difference | Purity | Endotoxins | Batch ID | Container | Tested At | Sent By |
| 15 Jan 2026 | View | 10mg | 10.1mg | +1.0% | 99.37% | n/a | MBRT10251116CBL | White Label / Silver Crimp / Clear Blue Cap | Lab E | Public | |
| 17 Dec 2025 | View | 10mg | 9.46mg | -5.4% | 99.89% | n/a | Sept 7,2025 | White Label / Silver Crimp / White Cap | Lab E | Public | |
| 4 Dec 2025 | View | 20mg | 21.1mg | +5.5% | 99.50% | not detected | (no batch ID) | No Label / Silver Crimp / Violet Cap | Lab E | Public | |
| 25 Nov 2025 | View | 10mg | 9.77mg | -2.3% | 99.95% | n/a | (no batch ID) | No Label / Silver Crimp / Clear Blue Cap | Lab E | Public | |
| 17 Nov 2025 | View | 20mg | 21.4mg | +7.0% | 99.07% | n/a | (no batch ID) | No Label / Copper Crimp / Clear Cap | Lab E | Public | |